US Jobless Claims Unexpectedly Dip for First Time in Three Weeks

(Bloomberg) — Applications for US unemployment insurance fell for the first time in three weeks, suggesting demand for labor remains healthy.

Initial unemployment claims decreased by 2,000 to 250,000 in the week ended Aug. 13, Labor Department data showed Thursday. The date is particularly scrutinized because it corresponds with the reference period for the government’s August employment report, which will be released early next month.

The median estimate in a Bloomberg survey of economists called for 264,000 applications.

Continuing claims for state benefits climbed to 1.44 million in the week ended Aug. 6, the highest since early April.

The drop in jobless claims points to still-healthy labor demand as companies try to attract and retain employees amid lingering worker shortages. Even so, several employers have been laying off staff or freezing hiring amid economic uncertainty, which could continue as the Federal Reserve pursues an aggressive path of interest-rate hikes.

However, Fed officials are cautious of raising rates too much in their fight to tame decades-high inflation, according to the minutes of their July meeting released Wednesday. They said the labor market remains strong, though jobless claims, which have generally been trending higher in recent months, point to some softening.

“A couple of participants indicated that firms were keen to retain workers — a factor that could limit the increase in layoffs associated with a slowing labor market,” policymakers said.

Among some of the companies reducing staffing levels are Apple Inc., crypto brokerage Genesis and Rapid Micro Biosystems Inc..

The claims data can be choppy week-to-week, and the prior period was revised down notably. The four-week moving average, which smooths out such swings, fell slightly to 246,750. That’s the first drop since early April.

On an unadjusted basis, initial claims decreased to 191,834 last week. California and Ohio fell the most, while claims in Massachusetts, which have been volatile in recent weeks, posted a large increase.

Do you think inflation in the US has peaked? This week’s MLIV Pulse survey takes a hard look at prices. Please follow this link to share your views.

 

More stories like this are available on bloomberg.com.

©2022 Bloomberg L.P.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More